Endothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity

J Clin Endocrinol Metab. 2013 Dec;98(12):4953-60. doi: 10.1210/jc.2013-2580. Epub 2013 Oct 8.

Abstract

Context: Endothelial colony-forming cells (ECFCs) are the only putative endothelial progenitor cells capable of vasculogenesis, and their dysfunction may represent a risk factor for cardiovascular disease. Intrauterine growth restriction (IUGR) is a pregnancy-related disorder associated with long-term cardiovascular risk.

Objective: Our objective was to determine whether ECFCs derived from pregnancies complicated by IUGR exhibit altered vasculogenic potential.

Design and setting: This was a prospective cohort study; patients were recruited at St. Mary's Hospital, Manchester, United Kingdom.

Participants: Twenty-three women with normal pregnancies and 13 women with IUGR-complicated pregnancies at gestational ages above 37 weeks were included.

Main outcome measures: Vasculogenic capacity of rigorously characterized ECFCs was investigated in vivo by measuring blood vessel formation in collagen/fibronectin gels implanted in mice; proliferative, migratory, and chemotactic abilities were assessed in cell culture. Placental uptake of fetal ECFCs, assessed by differences in arterial and venous cord blood content, was determined by flow cytometry.

Results: In vivo, IUGR ECFCs formed fewer blood vessels (P < .001) and capillaries (P = .001) compared with normal pregnancy-derived ECFCs. In culture conditions, IUGR ECFCs had reduced proliferation (P = .01) and migration (P = .007) and diminished chemotactic abilities to stromal cell-derived factor 1 (P = .007) coupled with reduced hypoxia-induced matrix metalloproteinase-2 release (P = .02). Finally, in IUGR pregnancies, the number of ECFCs was lower in arterial cord blood (P = .002) and placental uptake of cells was reduced (P < .001).

Conclusions: ECFCs derived from IUGR cord blood are rarefied and dysfunctional, resulting in diminished vasculogenic potential; this could be a cause of placental dysfunction in IUGR, with long-term postnatal implications for cardiovascular function in offspring.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Capillaries / enzymology
  • Capillaries / pathology
  • Capillaries / physiopathology
  • Cardiovascular Diseases / etiology
  • Cell Count
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Chemotaxis
  • Cohort Studies
  • Down-Regulation
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / pathology*
  • Endothelium, Vascular / physiopathology
  • Female
  • Fetal Blood
  • Fetal Growth Retardation / blood
  • Fetal Growth Retardation / enzymology
  • Fetal Growth Retardation / pathology*
  • Fetal Growth Retardation / physiopathology
  • Fetal Stem Cells / enzymology
  • Fetal Stem Cells / pathology*
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Neovascularization, Pathologic / enzymology
  • Neovascularization, Pathologic / pathology*
  • Neovascularization, Pathologic / physiopathology
  • Placenta / blood supply
  • Placenta / pathology
  • Pregnancy
  • Prospective Studies

Substances

  • MMP2 protein, human
  • Matrix Metalloproteinase 2